ECD organ involvement in NIH patients and in the literature
| Organ system and clinical findings . | NIH patients,* n (%) . | Veyssier-Belot et al† (%) . | Haroche et al‡ (%) . |
|---|---|---|---|
| Bone | 57 (95) | NR | 96 |
| Kidney | 39 (65) | 27 | 68 |
| Periaortic encasement | 37 (62) | NR | 66 |
| Hypogonadism | 36 (60) | NR | NR |
| Lung | 31 (52) | 14 | 43 |
| Bone pain | 28 (47) | 47 | 40 |
| Maxilla and mandible§ | 24 (47) | NR | NR |
| Diabetes insipidus | 28 (47) | 29 | 25 |
| CNS disease infiltration | 23 (38) | 17 | 51 |
| Retro-orbital area ± exophthalmos | 15 (27) | 29 | 25 |
| Heart (pseudotumor in RA) | 22 (37) | NR | 19 |
| Xanthelasma | 20 (33) | 19 | 28 |
| Skin | 15 (25) | 10 | NR |
| Pericardial disease | 5 (8) | 7 | 42 |
| Organ system and clinical findings . | NIH patients,* n (%) . | Veyssier-Belot et al† (%) . | Haroche et al‡ (%) . |
|---|---|---|---|
| Bone | 57 (95) | NR | 96 |
| Kidney | 39 (65) | 27 | 68 |
| Periaortic encasement | 37 (62) | NR | 66 |
| Hypogonadism | 36 (60) | NR | NR |
| Lung | 31 (52) | 14 | 43 |
| Bone pain | 28 (47) | 47 | 40 |
| Maxilla and mandible§ | 24 (47) | NR | NR |
| Diabetes insipidus | 28 (47) | 29 | 25 |
| CNS disease infiltration | 23 (38) | 17 | 51 |
| Retro-orbital area ± exophthalmos | 15 (27) | 29 | 25 |
| Heart (pseudotumor in RA) | 22 (37) | NR | 19 |
| Xanthelasma | 20 (33) | 19 | 28 |
| Skin | 15 (25) | 10 | NR |
| Pericardial disease | 5 (8) | 7 | 42 |